Literature DB >> 18453580

Administration of PLP139-151 primes T cells distinct from those spontaneously responsive in vitro to this antigen.

Romina Penitente1, Chiara Nicolò, Peter Van den Elzen, Gabriele Di Sante, Chiara Agrati, Francesca Aloisi, Eli E Sercarz, Francesco Ria.   

Abstract

We examined the TCR repertoire used by naive SJL mice in their in vitro spontaneous response to proteolipid protein (PLP) 139-151 by Vbeta-Jbeta spectratyping and compared it to that used after immunization with the peptide. T cells from immunized mice use the public rearrangement Vbeta10-Jbeta1.1, but naive mice do not; in contrast, TCR CDR3-beta rearrangements of Vbeta18-Jbeta1.2 and Vbeta19-Jbeta1.2 consistently are associated with the spontaneous response. T cells involved in spontaneous and induced responses can each recognize PLP(139-151) presented in vivo, but its s.c. administration has different consequences for the two repertoires. Four days after immunization, T cells associated with spontaneous responsiveness appear in the draining lymph nodes but disappear by day 10 and never appear elsewhere. Simultaneously, Vbeta10-Jbeta1.1 T cells are likewise activated in the lymph nodes by day 4 and spread to the spleen by day 10. Eight- to 10-wk-old naive mice use a narrower repertoire of TCRs than do immunized age-matched mice. Induced Vbeta10-Jbeta1.1 T cells home to the CNS during experimental autoimmune encephalomyelitis, whereas we failed to detect Vbeta18-Jbeta1.2 and Vbeta19-Jbeta1.2 TCR rearrangements in the CNS. Thus, we observe that administration of PLP(139-151) primes a T cell repertoire distinct from the one responsible for spontaneous responsiveness. This "immunized" repertoire substitutes for the naive one and becomes dominant at the time of disease onset.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453580     DOI: 10.4049/jimmunol.180.10.6611

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.

Authors:  Michela Sali; Gabriele Di Sante; Alessandro Cascioferro; Antonella Zumbo; Chiara Nicolò; Valentina Donà; Stefano Rocca; Annabella Procoli; Matteo Morandi; Francesco Ria; Giorgio Palù; Giovanni Fadda; Riccardo Manganelli; Giovanni Delogu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2.

Authors:  Chiara Nicolò; Gabriele Di Sante; Annabella Procoli; Giuseppe Migliara; Alessia Piermattei; Mariagrazia Valentini; Giovanni Delogu; Achille Cittadini; Gabriela Constantin; Francesco Ria
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

3.  PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model.

Authors:  Giuseppe Migliara; Martin Mueller; Alessia Piermattei; Chaya Brodie; Michael J Paidas; Eytan R Barnea; Francesco Ria
Journal:  Oncotarget       Date:  2017-03-28

4.  A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis.

Authors:  Maria Tredicine; Chiara Camponeschi; Davide Pirolli; Matteo Lucchini; Mariagrazia Valentini; Maria Concetta Geloso; Massimiliano Mirabella; Marco Fidaleo; Benedetta Righino; Camilla Moliterni; Ezio Giorda; Mario Rende; Maria Cristina De Rosa; Maria Foti; Gabriela Constantin; Francesco Ria; Gabriele Di Sante
Journal:  iScience       Date:  2022-01-11

5.  Restricted T-Cell Repertoire in the Epicardial Adipose Tissue of Non-ST Segment Elevation Myocardial Infarction Patients.

Authors:  Daniela Pedicino; Anna Severino; Gabriele Di Sante; Maria Cristina De Rosa; Davide Pirolli; Ramona Vinci; Vincenzo Pazzano; Ada F Giglio; Francesco Trotta; Giulio Russo; Aureliano Ruggio; Eugenia Pisano; Alessia d'Aiello; Francesco Canonico; Pellegrino Ciampi; Domenico Cianflone; Lorenzo Cianfanelli; Maria Chiara Grimaldi; Simone Filomia; Nicola Luciani; Franco Glieca; Piergiorgio Bruno; Massimo Massetti; Francesco Ria; Filippo Crea; Giovanna Liuzzo
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

6.  Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis.

Authors:  Francesco Ria; Romina Penitente; Maria De Santis; Chiara Nicolò; Gabriele Di Sante; Massimiliano Orsini; Dario Arzani; Andrea Fattorossi; Alessandra Battaglia; Gian Franco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2008-11-17       Impact factor: 5.156

7.  The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.

Authors:  Gabriele Di Sante; Susanna Amadio; Beatrice Sampaolese; Maria Elisabetta Clementi; Mariagrazia Valentini; Cinzia Volonté; Patrizia Casalbore; Francesco Ria; Fabrizio Michetti
Journal:  Cells       Date:  2020-03-18       Impact factor: 6.600

8.  S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.

Authors:  Chiara Camponeschi; Maria De Carluccio; Susanna Amadio; Maria Elisabetta Clementi; Beatrice Sampaolese; Cinzia Volonté; Maria Tredicine; Vincenzo Romano Spica; Rosa Di Liddo; Francesco Ria; Fabrizio Michetti; Gabriele Di Sante
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.